397 related articles for article (PubMed ID: 32047959)
21. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.
Gottenberg JE; Seror R; Miceli-Richard C; Benessiano J; Devauchelle-Pensec V; Dieude P; Dubost JJ; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Le Guern V; Morel J; Perdriger A; Puéchal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Nocturne G; Ravaud P; Mariette X
PLoS One; 2013; 8(5):e59868. PubMed ID: 23717383
[TBL] [Abstract][Full Text] [Related]
22. Increased levels of serum galectin-3 in patients with primary Sjögren's syndrome: associated with interstitial lung disease.
Zhang R; Sun T; Song L; Zuo D; Xiao W
Cytokine; 2014 Oct; 69(2):289-93. PubMed ID: 24981072
[TBL] [Abstract][Full Text] [Related]
23. Salivary free light chains and salivary immunoglobulins as potential non-invasive biomarkers in primary Sjögren's syndrome.
Sandhya P; Kabeerdoss J; Christudoss P; Arulraj R; Mandal SK; Janardana R; Chebbi PP; Ganesan MP; Mahasampath G; Danda D
Int J Rheum Dis; 2022 Jan; 25(1):61-69. PubMed ID: 34791797
[TBL] [Abstract][Full Text] [Related]
24. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
25. Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures.
Carrillo-Ballesteros FJ; Palafox-Sánchez CA; Franco-Topete RA; Muñoz-Valle JF; Orozco-Barocio G; Martínez-Bonilla GE; Gómez-López CE; Marín-Rosales M; López-Villalobos EF; Luquin S; Castañeda-Chávez A; Oregon-Romero E
Clin Exp Med; 2020 Nov; 20(4):615-626. PubMed ID: 32506205
[TBL] [Abstract][Full Text] [Related]
26. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
[TBL] [Abstract][Full Text] [Related]
27. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases.
Hernández-Molina G; Michel-Peregrina M; Hernández-Ramírez DF; Sánchez-Guerrero J; Llorente L
Rheumatology (Oxford); 2011 Jul; 50(7):1288-92. PubMed ID: 21330342
[TBL] [Abstract][Full Text] [Related]
28. Germinal centres in diagnostic labial gland biopsies of patients with primary Sjögren's syndrome are not predictive for parotid MALT lymphoma development.
Haacke EA; van der Vegt B; Vissink A; Spijkervet FKL; Bootsma H; Kroese FGM
Ann Rheum Dis; 2017 Oct; 76(10):1781-1784. PubMed ID: 28710097
[TBL] [Abstract][Full Text] [Related]
29. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and potential relevant factors of renal involvement in primary Sjögren's syndrome.
Luo J; Xu S; Lv Y; Huang X; Zhang H; Zhu X; Wang X
Int J Rheum Dis; 2019 Feb; 22(2):182-190. PubMed ID: 30411528
[TBL] [Abstract][Full Text] [Related]
31. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
[TBL] [Abstract][Full Text] [Related]
32. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
[TBL] [Abstract][Full Text] [Related]
33. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
[TBL] [Abstract][Full Text] [Related]
34. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
35. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
[TBL] [Abstract][Full Text] [Related]
36. Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren's syndrome.
Verstappen GM; Moerman RV; van Nimwegen JF; van Ginkel MS; Bijzet J; Mossel E; Vissink A; Hazenberg BPC; Arends S; Kroese FGM; Bootsma H
Rheumatology (Oxford); 2018 Oct; 57(10):1812-1821. PubMed ID: 29982712
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of germinal center-like structures in patients with Sjögren's syndrome.
He J; Jin Y; Zhang X; Zhou Y; Li R; Dai Y; Sun X; Zhao J; Guo J; Li Z
Int J Rheum Dis; 2017 Feb; 20(2):245-251. PubMed ID: 28556615
[TBL] [Abstract][Full Text] [Related]
38. Serum cystatin C is not an appropriate marker for kidney involvement in patients with primary Sjögren's syndrome.
Altunoğlu A; Erten Ş; Şahin A; Işıkoğlu S; Neşelioğlu S; Erzurum C; Erel Ö
Int J Rheum Dis; 2017 Mar; 20(3):371-375. PubMed ID: 25367815
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic utility of major salivary gland ultrasonography in primary Sjögren's syndrome.
Hammenfors DS; Brun JG; Jonsson R; Jonsson MV
Clin Exp Rheumatol; 2015; 33(1):56-62. PubMed ID: 25535773
[TBL] [Abstract][Full Text] [Related]
40. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
